Cesarean Delivery Withdrawn Phase 3 Trials for Bupivacaine (DB00297)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01303107Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in CesareanSupportive Care